Merge Healthcare acquires Confirma

With the completion of its acquisition of Confirma, Inc. today, Merge Healthcare Incorporated (NASDAQ: MRGE) has enhanced its medical imaging capabilities to become a market leader in MRI computer-aided detection (CAD) applications. The combined business now has the capability to widen the global adoption of CAD technology through Merge’s international distribution network, as well as provide broader interoperability of this important tool within the health IT enterprise. The newly merged organizations also enjoy many common customers.

“We are committed to offering patients premium patient care,” says Susan Curry, MD, Founder and Medical Director, Women’s Center for Radiology. “To ensure patients receive the best chance at earlier detection and treatment, it is vital that we provide patients with access to the most innovative technology available for medical imaging. As a long-time customer of both Merge Healthcare and Confirma, we are ecstatic that the two companies have joined forces and CADstream will now be included in Merge’s suite of offerings.”

Curry adds, “Merge Healthcare continues to redefine the medical imaging community, focusing on integrations that provide standard of care technology for improved quality, workflow and economics -- all important elements in today’s healthcare community.”

As part of the transaction Merge issued approximately 5.4 million shares of Merge Healthcare Common Stock. In addition, Merge will add approximately $2 million to Confirma’s existing cash balance in order to retire the outstanding debt and fund transaction-related costs. Confirma shareholders approved the merger on August 28, 2009.

Confirma will be renamed Merge CAD and operated as a business unit of Merge led by Paul Budak, a four year Confirma veteran who most recently served as the Vice President of Research, Development and Operations. Prior to joining Confirma, Budak started and managed a number of technology companies in the Seattle area. “Customers like Dr. Curry have welcomed this new step for Merge and Confirma,” says Budak, now President of Merge CAD, “because they understand the benefit of combining capabilities. CAD is an incredible workflow tool for improving the standardization, efficiency and economics of MRI studies; however, but it can go only so far as a standalone application. Merge’s connectivity experience and leading edge interoperability solutions will bring CAD to a whole new level of adoption.”

“This has been a straightforward transaction with a clear value proposition,” says Justin Dearborn, Merge CEO. “The Merge and Confirma teams both understand medical imaging technology at a very granular level and have a shared vision in ensuring that clinicians use it for faster and more efficient decision making. All stakeholders are anticipating that positive results will flow quickly from this newly combined business.”

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals AI's potential and pitfalls in medical diagnosis